SCHEMBL8091906

SCHEMBL8091906

C=C(Nc1cccc(OC)c1)c1ccc(OC)c(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.56
RAB9A P51151 5/20 0.56
ALDH1A1 P00352 5/20 0.54
TP53 P04637 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
KMT2A Q03164 2/20 0.54
PKM P14618 1/20 0.54
PDE4A P27815 2/20 0.52
PDE4B Q07343 2/20 0.52
PDE4C Q08493 2/20 0.52
PDE4D Q08499 2/20 0.52
POLB P06746 2/20 0.52
RXFP1 Q9HBX9 1/20 0.51
NLRP3 Q96P20 1/20 0.50
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
LMNA P02545 2/20 0.49
TRPV1 Q8NER1 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
PLAU P00749 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4248720 0.83 RXFP1 (0.76) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL8071365 0.82 NPC1 (0.56) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL8079371 0.79 NPC1 (0.65) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL8086822 0.79 ROCK2 (0.55) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL8086755 0.79 RAB9A (0.50) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL8086791 0.78 NPC1 (0.51) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL13391762 0.76 KMT2A (0.69) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL8086251 0.74 RAB9A (0.48) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL8086421 0.73 ALDH1A1 (0.64) NPC1RAB9AALDH1A1SMN1; SMN2KMT2A
SCHEMBL14395027 0.73 CYP2C9 (0.55) ALDH1A1SMN1; SMN2KMT2APKMPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009016088-A1 THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2009-02-05 WO disclosed